Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Navigating Labour’s potential new immigration system reform

Cambridge, UK, is renowned for its unique business environment that attracts and supports companies in various sectors. Navigating Labour's potential new policies and impacts on the labour market, and therefore the business landscape, will impact (positively and potentially negatively) the companies in Cambridge. This event has been postponed from September 2024.

If you work in HR or recruitment, are you prepared for the shifts in the labour market and immigration policies under Labour’s new administration? Join Davidson Morris for an insightful session where we’ll explore:

Occupational Health: How Management Referrals help businesses effectively manage and support employees’ health and wellbeing

Employee sickness absence and presenteeism can be detrimental to a business. Discover what value the Management Referral can add to your workplace.

A report by the Institute for Public Policy Research (IPPR) has found that the cost of employee sickness to UK businesses reached £103bn in 2023. In addition, employees lose the equivalent of 44 days of productivity through presenteeism as a result of an illness, injury, or specific health conditions.

Cambridge Network Connect

Join some of the Cambridge Network team and fellow members for an afternoon of networking over tea, cakes and fruit at Cambridge Network Connect (previously known as Making the Most of Membership).  If you want to meet like-minded companies and some new people, come and join us for a couple of hours. We’d love to meet you too. No presentations this time (ok, just a short welcome and introduction from our CEO)!

Event timings are:

Why is Cyber Security Key for Securing Life Sciences Partnerships?

Guest blog by RSM. 

As life sciences businesses grow and evolve, so too does the complexity of their data and third-party access landscape. From startups to mid-sized enterprises, strong cyber security fundamentals are essential to protecting research and intellectual property, safeguarding investor funds and confidence, and ensuring long-term success.

Nottingham-Based Inaphaea BioLabs Announces Promotion

Inaphaea BioLabs, the translational contract research organisation based at MediCity Nottingham, has announced the promotion of Melissa Barr to Head of Scientific Operations.

Melissa joined Inaphaea in 2023 as Lead Scientist. Since then, she has played an instrumental role in delivering preclinical drug discovery projects across oncology and women’s health, as well as leading a team of scientists on-site.

Key Dates for Your 2025 Diary

by Alicia Gailliez, Business Development Manager, One Nucleus

Over the past 12 months, One Nucleus has organised 41 events in partnership with 48 sponsors and supporters. These regular sessions were complemented by our flagship events, Genesis, ON Helix and the One Nucleus Annual Awards Dinner.

Looking ahead to 2025

“Broken Funding Model” Stifling University Spinout Sector, Says Survey

A lack of access to capital, particularly proof-of-concept funding, is stifling growth in the UK’s university spinout sector, according to a recent survey conducted by Symbiosis IP, a part of professional services group Gateley.

Described by one respondent as a “broken funding model”, the sector’s lack of funding and difficulty securing much-needed investment capital, particularly outside of the South East, are two of the most urgent issues facing the university spinout sector.

People Manager

At CHARM Therapeutics, we are pioneering the future of medicine design through the use of our protein-ligand intelligence platform to deliver next generation small molecule therapeutics.

Problem-Free Preparation of Active Form Membrane Proteins

AMSBIO announce a new range of Synthetic Nanodiscs that enable preparation of multi-pass transmembrane proteins in their active form, revolutionizing the future of membrane protein research and drug development. Membrane Proteins account for more than 60% of all FDA-approved drug targets and 90% of antibody-based drug targets. Many traditional sample preparation methods struggle with challenges in obtaining water-soluble and bioactive forms of multi-pass transmembrane proteins.

Subscribe to